TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3297325

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg p.o.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2122618

Group type: EXPERIMENTAL
Intervention: Chemoembolization (CHE)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Chemoembolization (CHE) as initial therapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Chemoembolization (CHE) with additional portal vein chemotherapy
Number of subjects: 21
Study: 49561

Group type: EXPERIMENTAL
Intervention: Oral sucrose plus electrolytes as a maintenance solution
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral sucrose plus electrolytes
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oral glucose‐electrolyte solutions
Number of subjects: 18
Study: 30869931

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) training with a 4‐hr standardized training and a 4‐week follow‐up coaching sessions
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Counselors in the experimental group
Number of subjects: 347

Group type: COMPARATOR
Intervention: Comparison group (no MI training)
Number of subjects: 347
Study: 27507402

Group type: EXPERIMENTAL
Intervention: Teduglutide 0.05 mg/kg/d
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Narcotic use
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 26594277

Group type: EXPERIMENTAL
Intervention: Flipped classroom model (asynchronous modules prior to shifts)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard learning method (modules performed at students' discretion)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Flipped classroom model
Number of subjects: 69
Study: 23595549

Group type: EXPERIMENTAL
Intervention: Surface electrical stimulation (SES) - motor-level stimulation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Surface electrical stimulation (SES) - sensory-level stimulation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Traditional logopedic dysphagia treatment
Number of subjects: 90
Study: 21921735

Group type: EXPERIMENTAL
Intervention: Harmonic Scalpel
Number of subjects: 31

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 31
Study: 19851433

Group type: EXPERIMENTAL
Intervention: Liquid sugars (1 sachet, 13 ml, ca. 5.2 g glucose, 5.2 g fructose, 5.2 g sucrose)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dextrose tablet (6 g)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Buccal glucose spray (10 doses, 0.84 g of glucose)
Number of subjects: 16
Study: 16830288

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate 2x400 mg, metronidazole 3x500 mg, and tetracycline 2x1000 mg for 14 days (RMT group)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pantoprazole 2x40 mg, bismuth subcitrate 4x300 mg, amoxicillin 2x1000 mg, and clarithromycin 2x500 mg for 14 days (PBAC group)
Number of subjects: 82
Study: 15340743

Group type: EXPERIMENTAL
Intervention: Diabetic patients undergoing CABG
Number of subjects: 2142

Group type: COMPARATOR
Intervention: Nondiabetic patients undergoing CABG
Number of subjects: 2142
Study: 11378663

Group type: EXPERIMENTAL
Intervention: OMC (40 mg omeprazole once a day, 500 mg metronidazole and 250 mg clarithromycin twice daily for 7 days)
Number of subjects: 55

Group type: COMPARATOR
Intervention: NA (300 mg nizatidine once a day and 1000 mg amoxicillin twice daily for 14 days)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Overall eradication rate after reallocation
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Reinfection rate after one year
Number of subjects: 55
Study: 8996144

Group type: EXPERIMENTAL
Intervention: Hormonal therapy (HT)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CT)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: RT plus HT plus CT
Number of subjects: 410

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: RT plus CT
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: RT plus HT
Number of subjects: 410
Study: 8356858

Group type: EXPERIMENTAL
Intervention: Propofol with 67% nitrous oxide in oxygen
Number of subjects: 65

Group type: COMPARATOR
Intervention: Propofol without nitrous oxide (O2)
Number of subjects: 65
Study: 2887885

Group type: EXPERIMENTAL
Intervention: Atenolol (10 mg IV every 6 h for 3 days, then 100 mg orally daily for 4 days)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 30841030

Group type: EXPERIMENTAL
Intervention: Propofol 3 mg/kg over 3 min
Number of subjects: 64

Group type: COMPARATOR
Intervention: No propofol (control group)
Number of subjects: 64
Study: 27496209

Group type: EXPERIMENTAL
Intervention: Transaxillary gasless endoscopic thyroidectomy (TGET)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional open thyroidectomy (COT)
Number of subjects: 33
Study: 25660046

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control solution (saline)
Number of subjects: 6
Study: 23238118

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program (twice‐weekly training for 12 weeks starting 1 month after hospital discharge)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 49
Study: 21531773

Group type: EXPERIMENTAL
Intervention: Video intervention explaining toddler drowning risk and CPR training
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 101
Study: 18097723

Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidectomy (PPH group)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Open hemorrhoidectomy (open group)
Number of subjects: 41
Study: 16832714

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.5 microg/day)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 12960633

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 10473925

Group type: EXPERIMENTAL
Intervention: Cefepime (2.0 g q. 8 h)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ceftazidime (2.0 g q. 8 h)
Number of subjects: 45
Study: 8935482

Group type: EXPERIMENTAL
Intervention: Oral sumatriptan 100 mg (second dose)
Number of subjects: 1349

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1349

Group type: EXPERIMENTAL
Intervention: Oral sumatriptan 100 mg (first dose)
Number of subjects: 1349
Study: 1930444

Group type: EXPERIMENTAL
Intervention: 12‐minute video demonstration of perineal massage
Number of subjects: 83

Group type: COMPARATOR
Intervention: Routine printed and verbal instruction (Control)
Number of subjects: 83
Study: 6352663

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 28707488

Group type: EXPERIMENTAL
Intervention: Carbetocin (100 μg IV)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Oxytocin (30 IU IV)
Number of subjects: 220
Study: 27855714

Group type: EXPERIMENTAL
Intervention: Mentalisation-based treatment (MBT-ED)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Specialist supportive clinical management (SSCM-ED)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups (MBT-ED and SSCM-ED)
Number of subjects: 68
Study: 24732651

Group type: EXPERIMENTAL
Intervention: Surgical decompression of lower extremity nerves
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control leg (contralateral limb)
Number of subjects: 42
Study: 23238499

Group type: EXPERIMENTAL
Intervention: salmon calcitonin 200 IU nasal spray daily + calcium 500 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: inactive nasal spray + calcium 500 mg
Number of subjects: 60
Study: 20404307

Group type: EXPERIMENTAL
Intervention: Canakinumab (anti-interleukin-1 therapy)
Number of subjects: 13
Study: 18307115

Group type: EXPERIMENTAL
Intervention: Structured discussion about the costs of dieting
Number of subjects: 63

Group type: COMPARATOR
Intervention: Structured discussion about the benefits of dieting
Number of subjects: 63
Study: 16491647

Group type: EXPERIMENTAL
Intervention: 25 g of glucose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 0
Study: 12215185

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study: 9677550

Group type: EXPERIMENTAL
Intervention: latanoprost 0.005%
Number of subjects: 9
Study: 10153428

Group type: EXPERIMENTAL
Intervention: Preprinted notes
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional notes
Number of subjects: 200
Study: 2240539

Group type: EXPERIMENTAL
Intervention: Intravenous diclofenac sodium
Number of subjects: 160

Group type: COMPARATOR
Intervention: Intramuscular diclofenac
Number of subjects: 160

Group type: COMPARATOR
Intervention: Intravenous fentanyl
Number of subjects: 160

Group type: COMPARATOR
Intervention: Intramuscular placebo
Number of subjects: 160
Study: 365312

Group type: EXPERIMENTAL
Intervention: Oral 5-fluorouracil (5-FU)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Intravenous 5-fluorouracil (5-FU)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Oral Methyl CCNU
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) and 6-thioguanine
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide and 5-fluorouracil (5-FU)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Crossover or previously treated patients
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Methyl CCNU
Number of subjects: 316
Study: 31566030

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily for 5 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Esomeprazole 20 mg once daily for 5 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lansoprazole 15 mg once daily for 5 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily for 5 days
Number of subjects: 12
Study: 30879775

Group type: EXPERIMENTAL
Intervention: Cavit G (3M ESPE)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Coltosol F (Coltène/Whaledent AG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intermediate Restorative Material (Dentsply Sirona)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DiaTemp (DiaDent Europe BV)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Negative control group (intact teeth)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Positive control group (no temporary filling material)
Number of subjects: 120
Study: 28244907

Group type: COMPARATOR
Intervention: Intravenous tranexamic acid (1 g bolus)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid (1.95 g orally 2 hours preoperatively)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study: 25823907

Group type: EXPERIMENTAL
Intervention: 4-week buprenorphine taper
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 1-week buprenorphine taper
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 2-week buprenorphine taper
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Expected Withdrawal Severity (baseline rating)
Number of subjects: 28
Study: 23578508

Group type: EXPERIMENTAL
Intervention: Degenerative aortic valves
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal aortic valves
Number of subjects: 22
Study: 21323599

Group type: EXPERIMENTAL
Intervention: Low-normal target TSH (0.4-2.0 mIU/L)
Number of subjects: 42

Group type: COMPARATOR
Intervention: High-normal target TSH (2.0-4.0 mIU/L)
Number of subjects: 42
Study: 19337757

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Posterolateral fusion (PLF)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Laminectomy
Number of subjects: 111

Group type: COMPARATOR
Intervention: Patients without ASD
Number of subjects: 111
Study: 17934662

Group type: EXPERIMENTAL
Intervention: Glimepiride 4 mg (Amaryl)
Number of subjects: 26
Study: 15525713

Group type: EXPERIMENTAL
Intervention: Intradermal injection of trivalent inactivated influenza vaccine (6 mug of hemagglutinin per antigen)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Intramuscular injection of standard dose of trivalent inactivated influenza vaccine (15 mug of hemagglutinin per antigen)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Intramuscular injection (control)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Intradermal injection
Number of subjects: 119
Study: 11266374

Group type: EXPERIMENTAL
Intervention: LCT (long-chain triglycerides)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: MCT (medium-chain triglycerides)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: LCT with THL (tetrahydrolipstatin)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: MCT with THL
Number of subjects: 15

Group type: COMPARATOR
Intervention: SPE (sucrose polyester)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: LCT
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: LCT with THL
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: MCT
Number of subjects: 15

Group type: COMPARATOR
Intervention: SPE
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: THL or SPE
Number of subjects: 15
Study: 9058868

Group type: EXPERIMENTAL
Intervention: VVIR 110
Number of subjects: 18
Study: 7574735

Group type: EXPERIMENTAL
Intervention: Plachitin (300 mg, 100 mg as CDDP) - Group A
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Plachitin particles (300 mg) - Group B
Number of subjects: 11

Group type: COMPARATOR
Intervention: CDDP (100 mg) - Group C
Number of subjects: 11
Study: 2114208

Group type: EXPERIMENTAL
Intervention: Topically applied cromolyn solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 638545

Group type: EXPERIMENTAL
Intervention: Dextran 70
Number of subjects: 305

Group type: COMPARATOR
Intervention: Pneumatic calf compression
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Dextran 70 and pneumatic calf compression (combined)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: All treatment groups (including control)
Number of subjects: 305
Study: 31602695

Group type: EXPERIMENTAL
Intervention: Crocus sativus capsules (30 mg daily, 15 mg twice/day)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo capsules (twice/day)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Crocus sativus capsules
Number of subjects: 73
Study: 30763425

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (HRT) 70 Gy in 28 fractions over 5.6 weeks
Number of subjects: 962

Group type: COMPARATOR
Intervention: Conventional radiotherapy (CRT) 73.8 Gy in 41 fractions over 8.2 weeks
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (HRT)
Number of subjects: 962

Group type: COMPARATOR
Intervention: Conventional radiotherapy (CRT)
Number of subjects: 962
Study: 28156154

Group type: EXPERIMENTAL
Intervention: Insulin timing intervention (injected or infused 30 minutes before the meal to 15 minutes after the meal)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standard insulin timing)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Insulin timing intervention (for volunteers with baseline A1C in the upper half)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (for volunteers with baseline A1C in the upper half)
Number of subjects: 40
Study: 24731892

Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Saj(®) cream
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150
Study: 22677689

Group type: EXPERIMENTAL
Intervention: 3-segment osteotomy (3SO)
Number of subjects: 98

Group type: COMPARATOR
Intervention: 2-segment osteotomy (2SO)
Number of subjects: 98
Study: 20192896

Group type: EXPERIMENTAL
Intervention: Sodium thiosulfate (STS) infusion
Number of subjects: 32

Group type: COMPARATOR
Intervention: No sodium thiosulfate (STS) infusion (Control)
Number of subjects: 32
Study: 18462572

Group type: EXPERIMENTAL
Intervention: Bulk-forming laxatives
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Stimulant laxatives
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Osmotic laxatives
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combination of laxatives
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: EuroQoL 5 Dimensions
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Reported number of bowel movements per week
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Presence/absence of the other Rome II criteria for constipation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Adverse effects of treatment
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Relapse rates
Number of subjects: 19
Study: 15854466

Group type: EXPERIMENTAL
Intervention: Artificial neural network model using serum protein fingerprint pattern
Number of subjects: 106
Study: 12939313

Group type: EXPERIMENTAL
Intervention: Adrenomedullin (12.8 pmol/(kg. min))
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Adrenomedullin co-infused with N(G)‐monomethyl‐L‐arginine (3 mg/kg bolus and 30 micro g/(kg. min) continuous intravenous infusion)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Adrenomedullin
Number of subjects: 8
Study: 10898265

Group type: EXPERIMENTAL
Intervention: Low resistance circuit weight training (CWT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Endurance training (END)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 90
Study: 7727267

Group type: EXPERIMENTAL
Intervention: Workload and Student Misbehaviour
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis on Sample 1 (N = 335)
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis on Sample 2 (N = 375)
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Structural modelling of causal relationships
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Simple regression model
Number of subjects: 710
Study: 1689245

Group type: EXPERIMENTAL
Intervention: Enteric coated microspheres (ECM)
Number of subjects: 20
Study: 6997374

Group type: EXPERIMENTAL
Intervention: Subunit adsorbed chemical influenza vaccine (ACI) administered subcutaneously by needleless and syringe methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Revaccination with ACI vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACI vaccine, 'Vaxgrip', and 'Mutagripe'
Number of subjects: 0
Study: 31923137

Group type: EXPERIMENTAL
Intervention: Brief intervention to increase STI screening and reduce sexual risk-taking behaviors
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Self-reported history of STI among women
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Self-reported history of STI among men
Number of subjects: 193
Study: 30037208

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g IV before induction, followed by 1 g IV infusion at 8-hour intervals for 48 hours)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 132
Study: 28330455

Group type: EXPERIMENTAL
Intervention: Exergames on Windows Kinect® (EG)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Instruction leaflets (CG)
Number of subjects: 54
Study: 26183659

Group type: EXPERIMENTAL
Intervention: Web-based program (n=32)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Usual self-care (n=33)
Number of subjects: 65
Study: 24103472

Group type: EXPERIMENTAL
Intervention: Go4it intervention (7 sessions with an interval of 2 weeks)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Current regular care (control group)
Number of subjects: 122
Study: 21237227

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2b (1.5μg/kg/wk) for 24 weeks + weight‐based ribavirin (800‐1200mg/d)
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2b (1.0μg/kg/wk) for 24 weeks + weight‐based ribavirin (800‐1200mg/d)
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2b (1.5μg/kg/wk) for 16 weeks + weight‐based ribavirin (800‐1200mg/d)
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: Undetectable HCV RNA at week 4
Number of subjects: 682
Study: 18946661

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 17372174

Group type: EXPERIMENTAL
Intervention: Oral deferiprone 75 mg/kg per day (combined group)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Subcutaneous deferoxamine (deferoxamine group)
Number of subjects: 65
Study: 15193576

Group type: EXPERIMENTAL
Intervention: Brief computer-mediated intervention (30-minute session)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control (regular programs without intervention)
Number of subjects: 205
Study: 11575053

Group type: EXPERIMENTAL
Intervention: Self‐help materials delivered by a physician with advice to change diet
Number of subjects: 2111
Study: 9709942

Group type: EXPERIMENTAL
Intervention: 16 mg/day DHT gel
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 32 mg/day DHT gel
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 64 mg/day DHT gel
Number of subjects: 25
Study: 7930274

Group type: EXPERIMENTAL
Intervention: Fixed dose subcutaneous heparin (12,500 U every 12 h delayed until 4 h after the end of streptokinase therapy)
Number of subjects: 28
Study: 3259071

Group type: EXPERIMENTAL
Intervention: Various treatments
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 29243341

Group type: EXPERIMENTAL
Intervention: 2% carteolol hydrochloride drops administered to the lesion surface twice daily for 6 months
Number of subjects: 349

Group type: COMPARATOR
Intervention: Observation (no treatment)
Number of subjects: 349
Study: 27306192

Group type: EXPERIMENTAL
Intervention: Ziprasidone augmentation
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 23574695

Group type: EXPERIMENTAL
Intervention: Behaviourally plus culturally tailored (BCT) information
Number of subjects: 623

Group type: COMPARATOR
Intervention: Behaviourally tailored (BT) information
Number of subjects: 623

Group type: COMPARATOR
Intervention: Generic information (GI)
Number of subjects: 623